Newsroom

Newsroom

Evaluation of a tumor informed MRD assay with contrived breast cancer samples

Literature
Read More

Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients

Literature
Read More

NeoGenomics to Announce First Quarter 2023 Financial Results

Press Release
Read More

Single-tube NGS profiling allows identification of molecular signature in ALL patients

Literature
Read More

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Press Release
Read More

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

Press Release
Read More

NeoGenomics to Host Investor Day on April 4, 2023

Press Release
Read More

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients